CBD drug Epidiolex received approval from the U.S. Food and Drug Administration to treat seizures associated with a third medical condition, expanding the range of indications for the cannabis-derived medication. The orally administered drug from Britain’s GW Pharmaceuticals previously was approved by the FDA to treat seizures associated with two forms of severe epilepsy, Lennox-Gastaut […]
FDA approves GW Pharmaceuticals’ cannabis drug for new indication is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Read More: FDA approves GW Pharmaceuticals’ cannabis drug for new indication
Comments are closed, but trackbacks and pingbacks are open.